A new study uncovers how diabetic red blood cells release toxic packages that damage blood vessels, revealing a promising path for preventing serious complications. EVs derived from RBCs of patients ...
EyePoint Pharmaceuticals outlines Phase 3 trials for Duravyu in diabetic macular edema, backed by $150 million in new funding ...
News-Medical.Net on MSN
Breakthrough enables large-scale cultivation of blood vessel cells
Scientists have discovered a method to induce human endothelial cells from a small biopsy sample to multiply in the ...
Laboratory research has shown that drugs such as semaglutide, already prescribed for type 2 diabetes and obesity, may shield ...
Sterling Glass had many health problems as a child—swollen feet, night sweats, nausea and vomiting, unquenchable thirst, and ...
Certain optical coherence tomography biomarkers may predict visual outcomes in patients with center-involving diabetic macular edema.
People with diabetes face a number of health challenges related to their chronic condition, and loss of vision due to retinal damage is one of them. Photo by Adobe Stock/HealthDay News People with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback